News Detail
Related News
News Detail

Razi Institute Expands Economic, Technological, and Scientific Ties with Tanzanian Government

en-news,inner news,branches,Media reflections,Announcements,conferences,workshops,exhibitions,Seminars,Multimedia
Publish Date : 18:00 - 2024/7/9
: Reading Time
On Tuesday, July 9th, 2024, the Razi Institute delegation, attending the 48th SABASABA Expo, organized a meeting with Dr. Adam Mitangu Fimbo, the Director General of the Tanzania Medicines and Medical Devices Authority (TMDA). During this session, representatives from Razi Vaccine and Serum Research Institute provided a detailed overview of the institute's rich history and activities, complemented by a promotional video showcasing Razi's impactful contributions.

One of the Key topics of the discussion was the imperative need for GMP (Good Manufacturing Practices) compliance for the successful introduction of Razi Institute's products into the Tanzanian market. This process involves the meticulous submission of documentation as required by the Tanzanian regulatory authorities.

 

Dr. Fimbo emphasized the institute's century-old heritage as a cornerstone for ensuring product quality and safety. However, he highlighted the need for modernization and structural improvement in operational processes and equipment. Dr. Fimbo underscored the importance of GMP certification as the first step in regulatory oversight and emphasized the continuous improvement and adherence to cGMP principles as critical aspects.

The meeting also highlighted the critical importance of verifying vaccine compatibility with the microorganisms prevalent in different regions. This highlighted the essential role of quality control laboratory testing in securing import licenses and ensuring product efficacy and safety standards.

New Comment :
Name: Email: Comment: